Intravenous vitamin D therapy reduces PTH-(1-84)/large C fragments ratio in chronic hemodialysis patients

Nephron - Clinical Practice

Volumn 98, Issue 3, 2004, Pages

  Kihara, Takashi ^a   Ichikawa, Haruo ^a   Morimoto, Hisanori ^a   Yano, Ai ^a   Akagi, Shigeru ^a   Nakao, Kazushi ^a   Kohmoto, Hiroko ^a,b   Wada, Jun ^a   Kumagai, Isao ^b   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Teraoka Memorial Hospital   (Japan)

Author keywords

Parathyroid hormone; PTH (1 84) large C PTH fragments ratio; Vitamin D i.v. therapy

Indexed keywords

22 OXACALCITRIOL; CALCITRIOL; PARATHYROID HORMONE; PARATHYROID HORMONE DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; MALE; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL;

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; CALCITRIOL; CALCIUM; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; ISOENZYMES; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PHOSPHORUS; RENAL DIALYSIS; RENAL OSTEODYSTROPHY; VITAMINS;

EID: 8344228415     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080680     Document Type: Article

References (20)

1. Slatopolsky E, Finch J, Clay P, et al: A novel mechanism for skeletal resistance in uremia. Kidney Int 2000;58:753-761.
2. Sherrard DJ, Hercz G, Pei Y, et al: The spectrum of bone disease in end-stage renal failure - An evolving disorder. Kidney Int 1993;43:436-442.
3. Kurz P, Monier-Faugere MC, Bognar B, et al: Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 1994;46:855-861.
4. Coco M, Rush H: Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 2000;36:1115-1121.
5. Atsumi K, Kushida K, Yamazaki K, et al: Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 1999;33:287-293.
6. Quarles LD, Lobaugh B, Murphy G: Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 1992;75:145-150.
7. Coen G, Ballanti P, Bonucci E, et al: Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Nephrol Dial Transplant 1998;13:2294-2302.
8. Monier-Faugere MC, Geng Z, Mawad H, et al: Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int 2001;60:1460-1468.
9. Nguyen-Yamamoto L, Rousseau L, Brossard JH, Lepage R, D'Amour P: Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor. Endocrinology 2001;142:1386-1392.
10. Qi Q, Monier-Faugere MC, Geng Z, Malluche HH: Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 1995;26:622-631.
11. Monier-Faugere MC, Malluche HH: Trends in renal osteodystrophy: A survey from 1983 to 1995 in a total of 2,248 patients. Nephrol Dial Transplant 1996;11(suppl 3):111-120.
12. Malluche HH, Mawad H, Trueba D, Monier-Faugee MC: Parathyroid hormone assays - Evolution and revolutions in the care of dialysis patients. Clin Nephrol 2003;59:313-318.
13. Lepage R, Roy L, Brossard JH, et al: A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 1998;44:805-809.
14. 3. Endocrinology 1999;140:3633-3642.
15. Waton PH, Mortimer ST, Wang KK, Croall DE, Hanley DA: Calcium-activated proteases in the bovine parathyroid gland: Potential role in degradation of parathyroid hormone to peptide fragments. J Mol Endocrinol 1995;15:61-71.
16. Zull JE, Chuang J: Characterization of parathyroid hormone fragments produced by cathepsin D. J Biol Chem 1985;260:1608-1613.
17. Sakwe AM, Engstrom A, Larsson M, Rask L: Biosynthesis and secretion of parathyroid hormone are sensitive to proteasome inhibitors in dispersed bovine parathyroid cells. J Biol Chem 2002;277:17687-17695.
18. Coen G, Bonucci E, Ballanti P, et al: PTH 1-84 and PTH '7-84' in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 2002;40:348-354.
19. Divieti P, John MR, Juppner H, Bringhurst FR: Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor. Endocrinology 2002;143:171-176.
20. Slatopolsky E, Weerts C, Thielan J, et al: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 1984;74:2136-2143.